发表部分代表性论著如下：
1.Wang LT,Wang YJ , Zhang YX, Chen SJ , Liu ZX, Cao JY, Ni WJ, Tao TT, Tang RN（通讯作者）, Zhang XL, Liu Bc. High phosphorus mediated the release ofC-X-C motif chemokine ligand 8 in valvular interstitial cells-inducedendothelial-to-mesenchymal transition via miR-214/phosphatase and tensinhomolog to promote valvular calcification in chronic kidney disease. Clinicaland Translational Medicine. 2022, 12: e733.
2.Wang LT,Tang RN（通讯作者）, ZhangYX, Chen SJ, Guo Y, Wang X, Liu Z, Liu H, Zhang X, Liu BC. PTH-induced EndMTvia miR-29a-5p/GSAP/Notch1 pathway contributed to valvular calcification inrats with CKD. Cell Prolif. 2021 Jun;54(6):e13018
3.Zhang YX, Tang RN（通讯作者）, Wang LT, Liu BC. Role of crosstalk betweenendothelial cells and smooth muscle cells in vascular calcification in chronickidney. 2021 Mar;54(3):e12980.
4.WangLT, Tang RN（共同一作，通讯作者）, Zhang YX, Liu Z, Chen S, Song K, Guo Y, ZhangL, Wang X, Wang X, Liu H, Zhang X, Liu BC. A Rat Model with MultivalveCalcification Induced by Subtotal Nephrectomy and High-Phosphorus Diet. KidneyDis (Basel). 2020 Sep;6(5):346-354.
5.Ni LH,Tang RN（共同一作）, Lv LL,Wu M, Wang B, Wang FM, Ni HF, Song KY, Wang LT, Meng-Zuo, Chen Q, Liu BC. A ratmodel of SHPT with bone abnormalities in CKD induced by adenine and a highphosphorus diet. Biochem Biophys Res Commun. 2018 Apr 6;498(3):654-659.
6.Ni LH,Tang RN（共同一作，通讯作者）, YuanC, Song KY, Wang LT, Zhang XL, Lv LL, Wang B, Wu M, Tang TT, Li ZL, Yin D, CaoJY, Wang XC, Liu H, Chen Q, Liu BC. Cinacalcet attenuated bone loss viainhibiting parathyroid hormone-induced endothelial-to-adipocyte transition inchronic kidney disease rats. Ann Transl Med. 2019 Jul;7(14):312
7.Ni LH,Yuan C, Song KY, Wang XC, Chen SJ, Wang LT, Zhang YX, Liu H, Liu BC, Tang RN（通讯作者）.Efficacy and safety of cinacalcet and active vitamin D in the treatment ofsecondary hyperparathyroidism in patients with chronic kidney disease: anetwork meta-analysis. Ann Transl Med. 2019 Jul;7(14):322.
8.Ni LH,Tang RN（共同一作，通讯作者）, YuanC, Song KY, Wang LT, Wang XC, Zhang YX, Zhang XL, Zhu DD, Liu BC. FK506prevented bone loss in streptozotocin-induced diabetic rats via enhancingosteogenesis and inhibiting adipogenesis. Ann Transl Med. 2019 Jun;7(12):265
9.Chen SJ, Lv LL, Liu BC, Tang RN（通讯作者）. Crosstalk between tubular epithelialcells and glomerular endothelial cells in diabetic kidney disease. Cell Prolif.2020 Mar;53(3):e12763.
10.WangLT, Tang RN（通讯作者）.DAPT alleviates CKD-related Coronary artery calcification bymodulating PTH-induced endothelial-to-osteobalst transition via Notch1 pathwayactivation.Cell Cycle.2022 (in review)
11.倪利华,刘必成,汤日宁等.从整合医学角度探讨CKD骨-血管轴病变的综合管理[J].中华肾脏病杂志,2018,34(12):947-950.
12.王立婷,汤日宁,刘必成等.慢性肾脏病-矿物质和骨代谢异常动物模型建立方法[J].中华医学杂志,2018,98(10):798-800.
13.倪利华,刘必成,汤日宁等.慢性肾脏病骨密度下降研究进展[J].中华医学杂
志,2018,98(4):317-320.
14倪利华,宋凯云,汪晓晨等.甲状旁腺素通过 Wnt/β-catenin 信号通路诱导内皮细胞发生内皮-脂肪细胞转分化[J].中华肾脏病杂志，2019,35(6): 432-440.
15.陈思洁,刘必成,汤日宁等.慢性肾脏病骨脂肪细胞在骨质疏松进展中的作用 [J].中华肾脏#39;times new roman', serif">-脂肪细胞转分化的机制探讨[J].中国骨质疏松杂志,2019,25(5):611-616.
17.宋凯云,刘必成,汤日宁等.内皮-足细胞对话在糖尿病肾病中的研究进展[J]. 中华肾脏病杂志,2019,35(3):231-235.
18.张朔凡,尹清,王桂花,王立婷,陈思洁,汤日宁,张晓良,刘必成.溴隐亭诱发腹膜后纤维化致急性肾损伤一例[J].中华肾脏病杂志,2020(03):237-238-239.
19.张朔凡,刘玉秋,伍敏,陈思洁,汤日宁,潘友文,张晓良,刘必成.美白化妆品导致的汞中毒相关性肾损害一例[J].中华肾脏病杂志,2020(05):397-399.
20．汪晓晨,王立婷,汤日宁,刘必成.慢性肾脏病患者心脏瓣膜钙化的研究进展[J].中华肾脏病杂志,2020,36(11):876-880.
21.汤日宁,汪晓晨,王立婷,陈思洁,张玉霞,张朔凡.慢性肾脏病患者心脏瓣膜钙化新危险因素分析[J].中国全科医学,2021,24(11):1365-1371.
22.张玉霞,汤日宁,刘必成.慢性肾脏病患者血管钙化发生机制研究进展[J].中华肾脏病杂志,2021,37(09):779-784.
23.廖梦,陈思洁,汤日宁,张晓良.内皮-间充质转分化在腹膜透析相关腹膜纤维化中的研究进展[J].临床肾脏病杂志,2021,21(10):848-855.
24.陈思洁,王凤梅,张晓良,刘必成,汤日宁.新型免疫抑制剂在狼疮肾炎治疗中的进展[J].中华肾脏病杂志,2021,37(11):937-944.
25.张朔凡,汤日宁,施璇,高月明,张晓良,刘必成.利妥昔单抗治疗难治性肾病综合征伴大量胸腔积液一例[J].临床肾脏病杂志,2021,21(12):1052-1054.
26.汪晓晨,汤日宁,刘必成.慢性肾脏病患者骨质疏松及血管钙化共同发病机制的研究进展[J].中国实用内科杂志,2021,41(06):554-557.
参编书目：
1.刘必成，汤日宁，等。肾脏纤维化-基础与临床。北京，科学出版社。2016.1
2.汤日宁，王美美。慢性缺血性肾病的诊治进展。内科学诊治进展。北京，军事医学科学出版社，2008.12
3.汤日宁，刘必成。慢性缺血性肾病诊治进展。慢性肾脏病：新理论与实践。南京，东南大学出版社，2008.1